Introduction to Tracheobronchomalacia

Tracheobronchomalacia (TBM) is a condition that affects the strength of the tracheal and bronchial walls, making them softer or weaker than normal. This can cause your airways to collapse, especially during exhalation or coughing. This could cause difficulties in breathing as well as other respiratory symptoms. 

TBM can either be congenital, meaning you were born with it due to improper development of the tracheal or bronchial cartilage, or it can be acquired over time. and can be classified into varying degrees of severity, from mild to life-threatening.  TBM can occur due to several factors such as prolonged intubation, trauma, or inflammatory diseases that cause damage to the airway walls.

The pathophysiology of TBM revolves around the structural insufficiency of the tracheal or bronchial cartilage, leading to reduced rigidity and support. The lack of adequate cartilage in the walls of the airways causes them to collapse more easily during the breathing cycle. This results in airflow obstruction and other significant respiratory symptoms, including wheezing, chronic cough, shortness of breath, and even respiratory failure. The severity of symptoms often depends on the degree of airway collapse and associated conditions, such as asthma or chronic obstructive pulmonary disease (COPD).

In severe cases of TBM, treatments such as bronchodilators and steroids may not be sufficient to manage symptoms. Surgical intervention is often required to provide lasting relief and improve quality of life. Surgical treatment can involve procedures aimed at restoring airway integrity, preventing further collapse, and enhancing respiratory function. The significance of surgery in severe cases cannot be overstated, as it provides a potential solution for patients who suffer from debilitating symptoms and recurrent respiratory infections that significantly impact their overall health.^1,2

Overview of Tracheobronchomalacia Symptoms and Diagnosis

Tracheobronchomalacia (TBM) presents a variety of symptoms that can range from mild to severe, often affecting a patient's ability to breathe comfortably. The hallmark signs of TBM are related to airway collapse and impaired airflow, which lead to respiratory distress. Common symptoms include chronic cough, wheezing, and shortness of breath, particularly during exertion or when the individual is exposed to irritants such as smoke or pollutants. In more severe cases, patients may experience significant respiratory distress, frequent respiratory infections, and even cyanosis (a bluish tint to the skin due to lack of oxygen).³

Common Symptoms

• Chronic Cough: One of the most prevalent symptoms of TBM is a persistent cough, which is often worse at night or after physical activity. The cough may be dry or accompanied by mucus and is caused by airway collapse during exhalation, leading to irritation and increased mucus production.
• Wheezing: As the airway walls become more flaccid, they are prone to collapse during breathing, which results in turbulent airflow. This turbulent airflow produces wheezing, a high-pitched whistling sound typically heard during exhalation.
• Shortness of Breath: Difficulty breathing or dyspnea occurs when the narrowed or collapsed airways obstruct normal airflow, especially during exertion or in situations where the airways are further constricted. This can lead to feelings of breathlessness and an increased effort required to breathe.
• Recurrent Respiratory Infections: Patients with TBM may experience frequent lung infections due to the constant irritation and potential stasis of secretions in the airways. This can lead to secondary infections, which further complicate the condition.
• Respiratory Distress: In more severe cases, individuals may experience significant respiratory distress and may require medical interventions such as supplemental oxygen or ventilatory support to maintain adequate oxygen levels in the blood.

Diagnostic Methods

To diagnose TBM, doctors use several imaging and diagnostic techniques to assess the degree of airway collapse and to rule out other l respiratory issues. Early and accurate diagnosis is key to determining the best treatment.

• Bronchoscopy: This is one of the most essential diagnostic tools for TBM. During a bronchoscopy, a thin, flexible tube equipped with a camera is inserted through the nose or mouth into the airways. This allows direct visualisation of the trachea and bronchi to assess the extent of airway collapse and identify any structural abnormalities or damage to the cartilage. Bronchoscopy is often performed under local anaesthesia and can also be used to obtain biopsies if necessary.
• CT Scans: High-resolution computed tomography (CT) scans are a vital imaging modality for assessing TBM. A CT scan provides detailed cross-sectional images of the airways, allowing clinicians to evaluate the degree of airway collapse and identify any underlying structural issues. It is particularly valuable for assessing the integrity of the tracheal and bronchial walls and accurately determining the extent of damage or weakness in the airway structure. Dynamic CT scans, taken while the patient is breathing, can offer additional insight into how the airways respond to changes in airflow.
• Pulmonary Function Tests (PFTs): Pulmonary function tests are non-invasive tests that measure the function of the lungs and airways. These tests can help determine the degree of airflow obstruction and assess the overall respiratory function. Common PFTs include spirometry, which measures the amount and speed of air a person can inhale and exhale, and peak flow measurements, which can help assess the severity of airflow limitation. PFTs can be useful in identifying patterns consistent with TBM, such as reduced forced expiratory volume (FEV1) or forced vital capacity (FVC).
• Dynamic Imaging Studies: In addition to static imaging techniques like CT scans, dynamic imaging methods such as fluoroscopy or dynamic MRI can be used to observe the motion of the airway during breathing. These techniques allow clinicians to see how the airways collapse and open during respiration, which can be particularly useful for assessing the severity of TBM.
• Exhaled Nitric Oxide Testing: Although not commonly used in diagnosing TBM, measuring exhaled nitric oxide can help differentiate TBM from other airway disorders like asthma, as higher levels of nitric oxide may indicate airway inflammation. However, this method is not specific to TBM and is typically used in conjunction with other diagnostic procedures.

Accurate diagnosis of TBM is essential in guiding treatment decisions and determining whether conservative management or surgical intervention is the most appropriate option.

Indications for Surgical Intervention

Surgical intervention for tracheobronchomalacia (TBM) is generally considered when conservative management fails to alleviate symptoms or when there’s a significant impairment in respiratory function. The decision to proceed with surgery depends on several factors, including the severity of symptoms, the degree of airway collapse, and the presence of associated complications. While surgery can offer substantial benefits in improving quality of life and preventing life-threatening episodes, it is not always necessary for every patient with TBM.⁴

Criteria for Surgical Treatment

• Failure of Conservative Management: For most patients with mild or moderate TBM, initial treatment involves conservative measures such as bronchodilators, inhaled corticosteroids, chest physiotherapy, and other airway clearance techniques. However, in severe cases where these measures are ineffective at controlling symptoms, surgical intervention may be necessary. If the patient's condition continues to worsen despite optimal medical management, surgical options should be explored.
• Severity of Symptoms: Surgical treatment is often indicated in patients who experience severe symptoms, such as chronic respiratory distress, frequent exacerbations, or a significant reduction in the quality of life due to persistent wheezing, coughing, and shortness of breath. In some cases, TBM may lead to respiratory failure, especially in those with underlying lung diseases, where surgery can provide a more permanent solution.
• Associated Complications: Patients who develop complications like recurrent respiratory infections, atelectasis (lung collapse), or frequent hospitalisations due to airway obstruction may benefit from surgical intervention. These complications can result from the impaired clearance of secretions and the collapse of airways during breathing, which increases the risk of infections. Additionally, patients who experience life-threatening episodes, such as severe airway collapse during exertion or infection, may require surgery to stabilise the airways and prevent further deterioration.
• Progressive or Life-Threatening Airway Obstruction: If TBM progresses to the point where it causes significant airway obstruction that is unresponsive to medical management, surgery is often recommended. This is particularly true in patients who face episodes of severe airway collapse that lead to hypoxia (low oxygen levels) or hypercapnia (elevated carbon dioxide levels), conditions that can be life-threatening if left untreated.
• Failure to Thrive in Children: In cases of congenital TBM, especially in infants and young children, surgical treatment may be necessary when the child exhibits failure to thrive, severe respiratory distress, or developmental delays due to the condition. Surgery can significantly improve respiratory function and help ensure normal growth and development.

Patient Selection Process and Preoperative Evaluation

Selecting candidates for surgery involves a comprehensive evaluation of the patient's overall health, the severity of TBM, and the presence of any comorbid conditions that could influence the outcome of surgery. The selection process typically includes the following steps:

• Thorough Medical History and Symptom Assessment: A detailed history of the patient's symptoms, including the duration, frequency, and intensity of respiratory distress, is critical in determining the need for surgery. The physician will also assess the impact of TBM on the patient’s daily life, such as limitations in physical activity, work, or school, as well as any history of recurrent infections or hospitalisations.
• Clinical Examination: A physical exam of the patient's respiratory status, including lung sounds, oxygen saturation levels, and overall respiratory effort. This exam helps determine the severity of airway compromise and provides additional information on the patient's suitability for surgery.
• Imaging and Diagnostic Studies: As part of the preoperative evaluation, imaging studies like CT scans or bronchoscopy are essential for assessing the degree of airway collapse and determining the best surgical approach. These diagnostic tools allow the surgical team to visualise the exact location and extent of the problem, which helps to choose the most appropriate procedure.
• Pulmonary Function Testing (PFTs): Pulmonary function tests assess the patient’s lung function and airflow. PFTs help determine whether the patient’s lungs are capable of tolerating surgery and if the surgery will significantly improve their ability to breathe. Reduced lung function or significant airflow limitation may indicate the need for a more aggressive surgical intervention.
• Assessment of Comorbidities: Patients with TBM may have other underlying health conditions, such as asthma, chronic obstructive pulmonary disease (COPD), or heart disease, which can complicate surgery. A thorough evaluation of these comorbid conditions is necessary to determine whether the patient can safely undergo surgical treatment. The presence of additional lung disease or cardiac issues may require consultation with other specialists to optimise perioperative care.
• Psychological and Social Considerations: Patients with TBM, particularly those with chronic symptoms or long-term dependence on medical management, may experience anxiety, depression, or stress due to the impact of the condition on their lifestyle. Addressing these psychological factors preoperatively is essential to ensure that the patient is mentally prepared for surgery and the potential recovery process.
• Multidisciplinary Team Involvement: The decision to perform surgery for TBM should involve a multidisciplinary team of specialists, including pulmonologists, thoracic surgeons, anesthesiologists, and respiratory therapists. This team approach ensures that all aspects of the patient’s care are considered and that the surgical treatment plan is tailored to the individual’s needs.

Preoperative evaluation and patient selection are crucial for optimising outcomes and minimising risks associated with surgery. Careful planning and a personalised approach to treatment ensure that surgical intervention is both necessary and beneficial for patients with severe TBM.⁵

Surgical Treatment Options for Tracheobronchomalacia

Tracheal Stenting

Tracheal stenting involves placing a tube-like device (stent) into the trachea or bronchi to maintain airway patency and prevent collapse. Stents are typically made of silicone, metallic alloys, or biodegradable polymers. 

Silicone stents are flexible, metallic stents are more rigid, and biodegradable stents gradually dissolve over time. This procedure is indicated for patients with severe airway collapse who do not respond to medical treatment. However, stenting can lead to complications such as stent migration, granulation tissue formation, and infection, requiring close monitoring.

Tracheobronchoplasty (Airway Reconstruction)

Tracheobronchoplasty, or airway reconstruction, aims to reinforce weakened or collapsed airways. Surgical techniques include cartilage grafts (often rib cartilage) or other autologous tissues to provide structural support. This procedure restores airway integrity and improves airflow. While it offers long-term benefits for patients with severe TBM, the risks include infection, graft rejection, or airway narrowing. The complexity of the procedure also increases with the extent of airway involvement.

Sleeve Resection and Anastomosis

Sleeve resection is a surgical technique that involves removing a segment of the airway, followed by reattaching the remaining portions through anastomosis. This technique is typically used when TBM involves localised airway collapse that cannot be addressed by stenting or reconstruction. Indications include tumours or severe distortion of the trachea or bronchi. The procedure requires careful planning to ensure proper reattachment. Potential complications include anastomotic leakage, infection, and difficulty maintaining airway patency post-surgery.

Lung Volume Reduction Surgery (LVRS)

In severe cases of TBM, especially when associated with emphysema or COPD, lung volume reduction surgery (LVRS) may be considered. LVRS involves removing damaged portions of the lung to reduce hyperinflation and improve respiratory mechanics. The procedure can relieve symptoms of TBM by allowing the lungs to expand more effectively. 

However, it is not suitable for all patients and is typically reserved for those with concomitant lung diseases. Postoperative care involves careful monitoring of lung function, as LVRS can lead to complications such as pneumothorax or infection.

Bronchial Stabilization with Biologic Mesh

Bronchial stabilisation with biological mesh involves using a mesh material made from organic tissue to support the weakened airways and prevent collapse. This mesh is typically made from materials like collagen or extracellular matrix derived from animal tissues. The mesh is placed around the bronchus to provide additional strength. 

While this method can be effective in stabilising the airway, it may lead to complications like mesh infection, rejection, or erosion into adjacent structures. The long-term durability of biologic mesh in TBM treatment is still under investigation.⁶

Future Trends in Surgical Treatment for Tracheobronchomalacia

Advances in surgical techniques and technology continue to shape the management of tracheobronchomalacia (TBM). Innovations in minimally invasive surgery, robotic assistance, and more precise imaging methods are enabling less invasive procedures with faster recovery times. These advancements help reduce complications and improve patient outcomes. Additionally, real-time dynamic imaging allows surgeons to assess airway function during the procedure, enhancing the precision of surgeries like tracheal reconstruction or stenting.

One promising area of research is the potential role of regenerative medicine and tissue engineering. Scientists are exploring stem cells, tissue scaffolds, and bioengineered cartilage to repair or replace damaged tracheal and bronchial tissues. This could lead to more effective, long-term solutions for patients with severe TBM. For instance, autologous stem cells might be used to regenerate cartilage, offering an alternative to traditional grafts or synthetic materials.

Research into the use of 3D printing technology is also advancing, with the potential to create custom airway stents or implants tailored to individual patients. This could lead to more personalised treatments, improving both functionality and comfort. Ongoing clinical trials are assessing these technologies, and may soon provide additional options for surgical intervention in TBM.

Summary

Tracheobronchomalacia (TBM) is a condition characterised by the weakening or collapse of the trachea and bronchi, which impairs airflow and can lead to severe respiratory symptoms. The condition can be congenital or acquired, with symptoms ranging from chronic cough and wheezing to respiratory failure in more severe cases. While conservative treatments are effective for mild cases, surgery becomes necessary when TBM leads to significant airway obstruction or recurrent respiratory infections.

Surgical treatment options for TBM include tracheal stenting, tracheobronchoplasty (airway reconstruction), sleeve resection and anastomosis, lung volume reduction surgery (LVRS), and bronchial stabilisation with biologic mesh. Each procedure is tailored to the severity and location of airway collapse, with benefits and risks specific to the individual patient. Postoperative care involves careful monitoring for complications, including infection or airway narrowing. As technology advances, the future of TBM surgery looks promising, with innovations in regenerative medicine, tissue engineering, and personalised treatment options such as 3D printing and robotic-assisted surgery.

FAQs

What are the common symptoms of tracheobronchomalacia?

Common symptoms of TBM include chronic cough, wheezing, shortness of breath, respiratory distress, and recurrent respiratory infections. These symptoms may worsen with physical activity or exposure to irritants.

When is surgery recommended for tracheobronchomalacia?

Surgery is recommended when conservative treatments fail to manage symptoms, or when the patient experiences severe respiratory distress, recurrent infections, or life-threatening airway obstruction. Surgical options are considered for patients with significant airway collapse or severe quality-of-life impairment.

What surgical treatments are available for TBM?

Surgical treatments for TBM include tracheal stenting (to prevent airway collapse), tracheobronchoplasty (airway reconstruction with cartilage grafts), sleeve resection and anastomosis (removal and reattachment of airway segments), lung volume reduction surgery (for patients with concurrent lung diseases), and bronchial stabilisation with biologic mesh.

What are the risks of tracheal stenting?

Risks associated with tracheal stenting include stent migration, infection, granulation tissue formation, airway injury, and stent-related complications such as obstruction or failure to provide adequate support.

How does the future of TBM surgery look?

The future of TBM surgery is focused on advances in minimally invasive techniques, regenerative medicine (such as stem cell therapy), and personalised treatments like 3D-printed airway devices. These innovations aim to improve patient outcomes, reduce recovery time, and offer more durable solutions for airway stabilisation.